Health

China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory

TAIZHOU, China, Jan. 16, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Ad...

2020-01-16 21:00 6144

LimaCorporate Inaugurates the New Research & Innovation Center for 3D Printing and the Advanced Laboratory for Testing and Analysis (ATLAs)

UDINE, Italy, Jan. 16, 2020 /PRNewswire/ -- LimaCorporate announces the official opening of new spaces entirely dedicated to 3D Printing and advanced testing: the Research & Innovation Center (R&I Center) and the Advanced Laboratory for Testing and Analysis (ATLAs). These new areas are located in...

2020-01-16 21:00 1841

Transamerica Life Bermuda's Excellent Customer Service Recognised at the Benchmark Wealth Management Awards

HONG KONG, Jan. 16, 2020 /PRNewswire/ -- Transamerica Life (Bermuda) Ltd. (TLB), a leading High Net Worth (HNW) life insurer, has won the "Outstanding Achiever" award at the 10th Benchmark Wealth Management Awards in Hong Kong in the category for "High Net Worth Client Servicing".   

2020-01-16 16:21 4648

"Every Person Deserves the Chance to Live a Healthy and Productive Life" -- 2020 BUTTON Healthcare Cross-Border Partnering Summit -- From Globe to Asia

HEFEI, China, Jan. 16, 2020 /PRNewswire/ -- On the morning of January 13, 2020 (Pacific Time), the 38th J.P. Morgan Healthcare Conference opened in San Francisco as scheduled. At the same time, the "BUTTON Healthcare Cross-Border Partnering Summit - From Globe toAsia" was grandly held at the Merc...

2020-01-16 16:11 1130

WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany

* First drug product facility in Europe to complement WuXi Biologics' existing commercial manufacturing capacities * WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer SHANGHAI and LEVERKUSEN, Germany, Jan. 15, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2020-01-16 10:39 17960

FDF China to be held in June to boost Chinese pharmaceutical enterprises to "go global" and promote the innovation and development of industry

SHANGHAI, Jan. 16, 2020 /PRNewswire/ -- FDF China, collocated with CPhI China, will be held fromJune 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implement strategic layout to step up cooperation in innovation and facilitate the inte...

2020-01-16 09:52 2129

Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline"

SEOUL, South Korea, Jan. 15, 2020 /PRNewswire/ -- The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Morgan Healthcare Conference inSan Francisco during Jan. 13-15, which it presented its vision and major R&D strategies for 2020. ...

2020-01-16 07:30 1500

Prudential chooses IMG to boost travel assistance offerings and introduce new product

INDIANAPOLIS, Jan. 16, 2020 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning global insurance benefits and assistance services company, has been chosen by The Prudential Insurance Company of America (Prudential) to provide increased travel assistance offerings and a new insu...

2020-01-16 01:30 17959

GenScript and Genopis Enter Into Strategic Partnership Agreement for Manufacture Service of GMP Plasmids

NANJING, China, Jan. 15, 2020 /PRNewswire/ -- On January 14, 2020, at San Francisco, USA, a global leading biotech company GenScript announced that it signed a strategic partnership agreement for the manufacturing service of GMP Plasmids with Genopis, Inc., a company that specializes in plasmid D...

2020-01-16 01:00 2060

Call for Application for 2020 Tsinghua Amgen Scholars Program

BEIJING, Jan. 15, 2020 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science. Thro...

2020-01-15 18:18 2341

AXA Hong Kong launches the first 'AXA Chronic Disease Management Programme'

HONG KONG, Jan. 15, 2020 /PRNewswire/ -- According to a recent survey conducted by AXA Hong Kong, comprising 1,000Hong Kong people, it is deduced that more than one-third of those surveyed have been diagnosed with chronic diseases in which this proportion increased to over 50% in the 45-60 age gr...

2020-01-15 15:41 3508

Europ Assistance opens new office in Thailand

BANGKOK, Jan. 15, 2020 /PRNewswire/ -- Europ Assistance today announced the opening of their new office inBangkok, Thailand to provide its world-renowned travel and medical networks to the region and complete the presence of the Generali Group inThailand. This is part of their overall plan to acc...

2020-01-15 09:00 2036

Medit Responds to Ongoing Patent Infringement Lawsuit in Germany

SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Medit today announced that there is an ongoing lawsuit inGermany in relation to European Patent no. 2 568 870 B1. The Regional Court of Duesseldorf in Germany rendered a judgment on January 9, 2020 (docket number 4c O 11/19), holding that Medit's...

2020-01-14 23:26 1717

ZAP Surgical Brain Tumor Treatments Commence at PLA General Hospital 301 in Beijing, China

SAN CARLOS, California, Jan. 14, 2020 /PRNewswire/ -- ZAP Surgical Systems, Inc. today announced that its ZAP-X® Gyroscopic Radiosurgery™ platform began clinical stereotactic radiosurgery (SRS) treatments at PLA General Hospital 301 (PLAGH 301) inBeijing, China. PLAGH 301 is the largest hospital ...

2020-01-14 23:07 2598

Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer

SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt,Germany and Pfizer Inc. to evaluate the safety, tolerability, biological and clinical ...

2020-01-14 08:00 3237

Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada

SUZHOU, China, Jan. 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or the "Company") (HKEX: 01801), a biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today announced tha...

2020-01-14 08:00 16018

Evolution 2.0 Prize: Unprecedented $10 Million Offered To Replicate Cellular Evolution

CHICAGO, Jan. 14, 2020 /PRNewswire/ --  An incentive prize ten times the size of the Nobel – believed to be the largest single award ever in basic science – is being offered to the person or team solving the largest mystery in history: how genetic code inside cells got there, and how cells intent...

2020-01-14 03:23 1123

Mentice Showcases First-of-Its-Kind Flexible Coronary Training Solution at IMSH 2020

CHICAGO, Jan. 14, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, will be showcasing the first of-its-kind flexible Coronary Essentials training solution at the 20th International Meeting on Simulation in Healthcare (IMSH 2020) inSan...

2020-01-14 03:15 1033

Volition Develops a New Improved Nu.Q™ Assay Format

AUSTIN, Texas, Jan. 13, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today provided an update on its Nu Q™ Clinical Assays which use a magnetic particle-based assay format. Volition has completely re-engineered its Nu.Q™ assays leading to a step-change improvement in...

2020-01-13 22:00 16145

WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform

PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advance therapies industry, announced today the expansion of its service capabilities by offering a fully ...

2020-01-13 22:00 6479
1 ... 840841842843844845846 ... 858